http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02085245-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f26b1f6602f3e9075c5c7a09fe0f8d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36046
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2002-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0842cf184ec2205031335c2037b13c6
publicationDate 2002-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02085245-A2
titleOfInvention Visual enhancement through refractive pupillary control
abstract A method for improving visual acuity of a patient is provided. The method includes fixing to an eye (10) of the patient an active element (26) so as to be capable of controlling an amount of light entering the eye. An electrical signal is applied to the active element, typically so as to modulate a diameter of the pupil (18) of the eye (10) .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1865826-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008100392-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008101897-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8070688-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102007008375-B3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1865826-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008100392-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008532722-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012210442-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8403483-B2
priorityDate 2001-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5066301-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4816031-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22251431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451620180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID228404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129024616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129002180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136206743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413074

Total number of triples: 44.